Functional heterogeneity of nociceptin/orphanin FQ receptors revealed by (+)-5a Compound and Ro 64-6198 in rat periaqueductal grey slices

International Journal of Neuropsychopharmacology

Volumn 14, Issue 7, 2011, Pages 977-989

  Liao, Yan Yu ^a   Teng, Shu Fang ^a   Lin, Li Chun ^a   Kolczewski, Sabine ^c   Prinssen, Eric P ^c   Lee, Li Jen ^a   Ho, Ing Kang ^d   Chiou, Lih Chu ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c F HOFFMANN LA ROCHE LTD   (Switzerland)

^d NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

(+) 5a Compound; nociceptin orphanin FQ receptors; periaqueductal grey; potassium channels; Ro 64 6198

Indexed keywords

(3A,6A) 1 (4 ISOPROPYLCYCLOHEXYL) 5' METHYL 2' PHENYLHEXAHYDROSPIRO(PIPERIDINE 4,1' PYRROLO[3,4 C]PYRROLE); 8 (2,3,3A,4,5,6 HEXAHYDRO 1H PHENALEN 1 YL) 1 PHENYL 1,3,8 TRIAZASPIRO[4.5]DECAN 4 ONE; G PROTEIN COUPLED INWARDLY RECTIFYING POTASSIUM CHANNEL; GLUTAMATE DECARBOXYLASE 67; NOCICEPTIN RECEPTOR; NOCICEPTIN RECEPTOR AGONIST; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CELL SIZE; CELL STRUCTURE; CONTROLLED STUDY; DENDRITE; GABAERGIC SYSTEM; IMMUNOFLUORESCENCE; NERVE CELL MEMBRANE POTENTIAL; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; G PROTEIN-COUPLED INWARDLY-RECTIFYING POTASSIUM CHANNELS; GLUTAMATE DECARBOXYLASE; IMIDAZOLES; MEMBRANE POTENTIALS; NEURONS; OPIOID PEPTIDES; PATCH-CLAMP TECHNIQUES; PERIAQUEDUCTAL GRAY; PYRIDINES; RATS; RATS, WISTAR; RECEPTORS, OPIOID; SPIRO COMPOUNDS;

EID: 80052963582     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S146114571000129X     Document Type: Article

References (48)

1. Anton B, Fein J, To T, Li X, et al. (1996). Immunohisto-chemical localization of ORL-1 in the central nervous system of the rat. Journal of Comparative Neurology 368, 229-251. (Pubitemid 26132542)
2. Barnes TA, Lambert DG (2004). Editorial III: Nociceptin/orphanin FQ peptide-receptor system: are we any nearer the clinic? British Journal of Anaesthesia 93, 626-628. (Pubitemid 39445541)
3. Beitz AJ, Shepard RD (1985). The midbrain periaqueductal gray in the rat. II. A Golgi analysis. Journal of Comparative Neurology 237, 460-475. (Pubitemid 15072863)
4. Burmeister MA, Ansonoff MA, Pintar JE, Kapusta DR (2008). Nociceptin/orphanin FQ (N/OFQ)-evoked bradycardia, hypotension, and diuresis are absent in N/OFQ peptide (NOP) receptor knockout mice. Journal of Pharmacology and Experimental Therapeutics 326, 897-904.
5. Calò G, Bigoni R, Rizzi A, Guerrini R, et al. (2000). Nociceptin/orphanin FQ receptor ligands. Peptides 21, 935-947.
6. Chiou LC, Chuang KC, Wichmann J, Adam G (2004). Ro 64-6198 [(1S,3aS)-8-(2,3,3a,4,5,6-Hexahydro-1H-phenalen-1-yl)-1-phenyl-1,3, 8-triaza-spiro[4.5]decan-4-one] acts differently from nociceptin/orphanin FQ in rat periaqueductal gray slices. Journal of Pharmacology and Experimental Therapeutics 311, 645-651. (Pubitemid 39391551)
7. Chiou LC, Fan SH, Guerrini R, Calò G (2002). [Nphe1]N/OFQ-(1-13)- NH2 is a competitive and selective antagonist at nociceptin/orphanin FQ receptors mediating K+ channel activation in rat periaqueductal gray slices. Neuropharmacology 42, 246-252. (Pubitemid 34137028)
8. Chiou LC, Liao YY, Fan PC, Kuo PH, et al. (2007). Nociceptin/orpahnin FQ peptide receptors: pharmacology and clinical implications. Current Drug Targets 8, 117-135.
9. Chiou LC, Liao YY, Guerrini R, Calò G (2005). [Nphe1,Arg14,Lys15] N/OFQ-NH2 is a competitive antagonist of NOP receptors in the periaqueductal gray. European Journal of Pharmacology 515, 47-53. (Pubitemid 40779267)
10. Dayan LA, Kenigs VA, Jenck F, Wichmann J, et al. (2001). Central injection of Ro 64-6198, synthetic ORL-1 agonist, produces profound nociceptin-like effects on kidney function and feeding but not cardiovascular function. FASEB Journal 15, A1143.
11. Dooley CT, Houghten RA (1996). Orphanin FQ: receptor binding and analog structure activity relationships in rat brain. Life Sciences 59, PL23-PL29. (Pubitemid 26199214)
12. Economidou D, Fedeli A, Fardon RM, Weiss F, et al. (2006). Effect of novel nociceptin/orphanin FQ-NOP receptor ligands on ethanol drinking in alcohol-preferring msP rats. Peptides 27, 3299-3306. (Pubitemid 44738195)
13. Erlander MG, Tillakaratne NJ, Feldblum S, Patel N, et al. (1991). Two genes encode distinct glutamate decarboxylases. Neuron 7, 91-100.
14. Goeldner C, Reiss D, Wichmann J, Meziane H, et al. (2008). Nociceptin receptor impairs recognition memory via interaction with NMDA receptor-dependent mitogen-activated protein kinase/extracellular signal-regulated kinase signaling in the hippocampus. Journal of Neuroscience 28, 2190-2198. (Pubitemid 351317630)
15. Henderson G, McKnight AT (1997). The orphan opioid receptor and its endogenous ligand-nociceptin/orphanin FQ. Trends in Pharmacological Sciences 18, 293-300. (Pubitemid 27353247)
16. Hirao A, Imai A, Sugie Y, Yamada Y, et al. (2008). Pharmacological characterization of the newly synthesized nociceptin/orphanin FQ-receptor agonist 1-[1-(1-methylcyclooctyl)-4-piperidinyl]-2-[(3R)-3-piperidinyl]-1H- benzimidazole as an anxiolytic agent. Journal of Pharmacological Sciences 106, 361-368. (Pubitemid 351468588)
17. Ikeda K, Kobayashi K, Kobayashi T, Ichikawa T, et al. (1997). Functional coupling of the nociceptin/orphanin FQ receptor with the G-protein-activated K+ (GIRK) channel. Brain Research. Molecular Brain Research 45, 117-126. (Pubitemid 27182231)
18. Jenck F, Moreau JL, Martin JR, Kilpatrick GJ, et al. (1997). Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress. Proceedings of the National Academy of Sciences USA 94, 14854-14858. (Pubitemid 28041464)
19. Jenck F, Wichmann J, Dautzenberg FM, Moreau JL, et al. (2000). A synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: anxiolytic profile in the rat. Proceedings of the National Academy of Sciences USA 97, 4938-4943. (Pubitemid 30238661)
20. Ko MC, Woods JH, Fantegrossi WE, Galuska CM, et al. (2009). Behavioral effects of a synthetic agonist selective for nociceptin/orphanin FQ peptide receptors in monkeys. Neuropsychopharmacology 34, 2088-2096.
21. Kolczewski S, Adam G, Cesura AM, Jenck F, et al. (2003). Novel hexahydrospiro[piperidine-4,1k-pyrrolo[3,4-c]-pyrroles]: highly selective small-molecule nociceptin/orphanin FQ receptor agonists. Journal of Medicinal Chemistry 46, 255-264. (Pubitemid 36082868)
22. Kuzmin A, Madjid N, Johansson B, Terenius L, et al. (2009). The nociceptin system and hippocampal cognition in mice: a pharmacological and genetic analysis. Brain Research 1305 (Suppl.), S7-S19.
23. Kuzmin A, Sandin J, Terenius L, Ogren SO (2004). Evidence in locomotion test for the functional heterogeneity of ORL-1 receptors. British Journal of Pharmacology 141, 132-140. (Pubitemid 38241171)
24. Lambert DG (2008). The nociceptin/orphanin FQ receptor: a target with broad therapeutic potential. Nature Reviews Drug Discovery 7, 694-710.
25. Liao YY, Trapella C, Chiou LC (2009). 1-Benzyl-N-[3-[spiroisobenzofuran- 1(3H),4k-piperidin-1-yl] propyl]pyrrolidine-2-carboxamide (Compound 24) antagonizes NOP receptor-mediated potassium channel activation in rat periaqueductal gray slices. European Journal of Pharmacology 606, 84-89.
26. Majumdar S, Mathis JP, Ansonoff M, Burgman M, et al. (2009). Binding of 125I-Y10-OFQ/N (1-11) in ORL1 knock out mice. International Narcotics Research Conference Program & Abstracts, 2009 (pp. 111). Portland, Oregon, USA: INRC.
27. Mathis JP, Goldberg IE, Letchworth SR, Ryan-Moro JP,etal. (1999). Identification of a high-affinity orphanin FQ/nociceptin(1-11) binding site in mouse brain. Synapse 34, 181-186. (Pubitemid 29508593)
28. Mathis JP, Ryan-Moro J, Chang A, Hom JS, et al. (1997). Biochemical evidence for orphanin FQ/nociceptin receptor heterogeneity in mouse brain. Biochemical and Biophysical Research Communications 230, 462-465. (Pubitemid 27212021)
29. Mei J, Pasternak GW (2007). Modulation of brainstem opiate analgesia in the rat by sigma 1 receptors: a microinjection study. Journal of Pharmacology and Experimental Therapeutics 322, 1278-1285. (Pubitemid 47295818)
30. Meunier JC, Mollereau C, Toll L, Suaudeau C, et al. (1995). Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature 377, 532-535.
31. Mogil JS, Pasternak GW (2001). The molecular and behavioral pharmacology of the orphanin FQ/nociceptin peptide and receptor family. Pharmacological Reviews 53, 381-415. (Pubitemid 32852018)
32. Mollereau C, Parmentier M, Mailleux P, Butour JL, et al. (1994). ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization. FEBS Letters 341, 33-38.
33. Mugnaini E, Oertel WH (1985). An atlas of the distribution of GABAergic neurons and terminals in the rat CNS as revealed by GAD immunohistochemistry. Handbook of Chemical Neuroanatomy 4, 436-608.
34. NC-IUPHAR. 2004. IUPHAR receptor database: opioid receptors. (http://www.iuphar-db.org/iuphar-rd/).
35. Neal CR, Mansour A, Reinscheid R, Nothacker HP, et al. (1999). Opioid receptor-like (ORL1) receptor distribution in the rat central nervous system: comparison of ORL1 receptor mRNA expression with 125I-[14Tyr]-orphanin FQ binding. Journal of Comparative Neurology 412, 563-605. (Pubitemid 29409672)
36. Obara I, Przewlocki R, Przewlocka B (2005). Spinal and local peripheral antiallodynic activity of Ro64-6198 in neuropathic pain in the rat. Pain 116, 17-25. (Pubitemid 40828496)
37. Peluso J, LaForge KS, Matthes HW, Kreek MJ, et al. (1998). Distribution of nociceptin/orphanin FQ receptor transcript in human central nervous system and immune cells. Journal of Neuroimmunology 81, 184-192. (Pubitemid 28248199)
38. Pillot C, Heron A, Cochois V, Tardivel-Lacombe J, et al. (2002). A detailed mapping of the histamine H(3) receptor and its gene transcripts in rat brain. Neuroscience 114, 173-193. (Pubitemid 35247499)
39. Reichling DB, Basbaum AI (1990). Contribution of brainstem GABAergic circuitry to descending antinociceptive controls: I. GABA-immunoreactive projection neurons in the periaqueductal gray and nucleus raphe magnus. Journal of Comparative Neurology 302, 370-377.
40. Reinscheid RK, Nothacker HP, Bourson A, Ardati A, et al. (1995). Orphanin FQ: a neuropeptide that activates an opioid like G protein-coupled receptor. Science 270, 792-794.
41. ReissD, WichmannJ, Tekeshima H, Kieffer BL, et al. (2008). Effects of nociceptin/orphanin FQ receptor (NOP) agonist, Ro64-6198, on reactivity to acute pain in mice: comparison to morphine. European Journal of Pharmacology 579, 141-148.
42. Rizzi D, Bigoni R, Rizzi A, Jenck F, et al. (2001). Effects of Ro 64-6198 in nociceptin/orphanin FQ-sensitive isolated tissues. Naunyn-Schmiedebergs Archives of Pharmacology 363, 551-555. (Pubitemid 32417813)
43. Sanada M, Zheng F, Huth T, Alzheimer C (2007). Cholinergic modulation of periaqueductal grey neurons: does it contribute to epileptogenesis after organophosphorus nerve agent intoxication? Toxicology 233, 199-208. (Pubitemid 46498376)
44. Shoblock JR (2007). The pharmacology of Ro 64-6198, a systemically active, nonpeptide NOP receptor (opiate receptor-like 1, ORL-1) agonist with diverse preclinical therapeutic activity. CNS Drug Reviews 13, 107-136. (Pubitemid 46697844)
45. Varty GB, Lu SX, Morgan CA, Cohen-Williams ME, et al. (2008). The anxiolytic-like effects of the novel, orally active nociceptin opioid receptor agonist 8-[bis(2-methylphenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octan-3-ol (SCH 221510). Journal of Pharmacology and Experimental Therapeutics 326, 672-682.
46. Vaughan CW, Ingram SL, Christie MJ (1997). Actions of the ORL1 receptor ligand nociceptin on membrane properties of rat periaqueductal gray neurons in vitro. Journal of Neuroscience 17, 996-1003. (Pubitemid 27043958)
47. Wichmann J, Adam G, Rover S, Hennig M, et al. (2000). Synthesis of (1S,3aS)-8-(2,3,3a,4,5,6-hexahydro-1H-phenalen-1-yl)-1-phenyl-1,3, 8-triaza-spiro[4.5]decan-4-one, a potent and selective orphanin FQ (OFQ) receptor agonist with anxiolytic-like properties. European Journal of Medicinal Chemistry 35, 839-851.
48. Zhang H, Cuevas J (2005). Sigma receptor activation blocks potassium channels and depresses neuroexcitability in rat intracardiac neurons. Journal of Pharmacology and Experimental Therapeutics 313, 1387-1396. (Pubitemid 40727046)